Adenosine receptors: new opportunities for future drugs. (Q40849413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Adenosine receptors: new opportunities for future drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

13 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

13 November 2019

author name string

S A Poulsen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

English

0 references

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

13 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

13 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

619-641

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

Adenosine receptors: targets for future drugs

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Subclasses of external adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Towards a revised nomenclature for P1 and P2 receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

1 reference

7 January 2021

Adenosine receptor subtypes: characterization and therapeutic regulation

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine: The prototypic neuromodulator

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Purine nucleotide metabolism in the cat brain after one hour of complete ischemia

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Changes in brain adenosine during bicuculline-induced seizures in rats. Effects of hypoxia and altered systemic blood pressure

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

A role for central A3-adenosine receptors. Mediation of behavioral depressant effects

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat.

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Mast cell degranulation following adenosine A3 receptor activation in rats

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

A role for mast cells in adenosine A3 receptor‐mediated hypotension in the rat

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Novel therapeutics acting via purine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Cardiovascular effects of adenosine in man; possible clinical implications

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine and Neuropsychiatric Disorders

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Neuroprotective effects of adenosine

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Neuroprotective role of adenosine in cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Purinergic mechanisms in epilepsy

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

The effect of theophylline on parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

The role of protein kinase C in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Preconditioning of human myocardium with adenosine during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

The cardiac effects of adenosine

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Mapping the N6-region of the adenosine A1 receptor with computer graphics

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

2-aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

2-(N'-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

2-(N'-aralkylidenehydrazino)adenosines: potent and selective coronary vasodilators

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Nucleosides and nucleotides. 103. 2-Alkynyladenosines: a novel class of selective adenosine A2 receptor agonists with potent antihypertensive effects

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Nucleosides and nucleotides. 107. 2-(Cycloalkylalkynyl)adenosines: adenosine A2 receptor agonists with potent antihypertensive effects

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

1 reference

7 January 2021

Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular cloning and characterization of the human A3 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

1,3,8-trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

(E)-1,3-Dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Derivatives of the triazoloquinazoline adenosine antagonist (CGS18633) are selective for the human A3 receptor subtype

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Partial agonism of theophylline-7-riboside on adenosine receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Ribose-Modified Adenosine Analogs as Potential Partial Agonists for the Adenosine Receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

A Computer Generated Model of Adenosine Receptors Rationalising Binding and Selectivity of Receptor Ligands

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

The three binding domain model of adenosine receptors: molecular modeling aspects

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Antagonism of presynaptic adenosine receptors by theophylline 9-β-D-riboside and 8-phenyltheophylline

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine receptors and their modulators

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Projection structure of rhodopsin

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Identification of Domains of the Human A1 Adenosine Receptor That Are Important for Binding Receptor Subtype-selective Ligands Using Chimeric A1/A2a Adenosine Receptors

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Differential interaction with and regulation of multiple G-proteins by the rat A3 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Selective amplification and cloning of four new members of the G protein-coupled receptor family

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord.

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Cloning and functional characterization of a human A1 adenosine receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular cloning and characterisation of a human brain A1 adenosine receptor cDNA

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Cloning and expression of a bovine adenosine A1 receptor cDNA

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Cloning of an adenosine A1 receptor-encoding gene from rabbit

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

RDC8 codes for an adenosine A2 receptor with physiological constitutive activity

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular cloning of a novel adenosine receptor gene from rat brain.

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular characterization of a human brain adenosine A2 receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Cloning and expression of the A2a adenosine receptor from guinea pig brain.

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular cloning and expression of an adenosine A2b receptor from human brain

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Is adenosine an endogenous anticonvulsant?

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Behavioral characteristics of centrally administered adenosine analogs

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine receptors and cardiovascular function

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Atrioventricular nodal accommodation in isolated guinea pig hearts: physiological significance and role of adenosine

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine analogs and human platelets. Effects on nucleotide pools and the aggregation phenomenon

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

5'-Methylthioadenosine and 2',5'-dideoxyadenosine blockade of the inhibitory effects of adenosine on ADP-induced platelet aggregation by different mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Inhibition of platelet aggregation by adenosine receptor agonists

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Two distinct adenosine-sensitive sites on adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Nucleotide and Nucleoside Stimulation of Glucagon Secretion

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

Adenosine analogs inhibit gastric acid secretion

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

The site of action of muscle relaxant purine nucleosides

1 reference

https://api.crossref.org/works/10.1016/S0968-0896(98)50038-8

7 January 2021

10.1016/S0968-0896(98)00038-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681130 AND SRC:MED&resulttype=core&format=json

13 November 2019

1 reference